The global active pharmaceutical ingredients (API) market is expected to reach a value of USD 239.8 billion by 2025, based on a new report by Grand View Research, Inc. The rising prevalence of lifestyle-induced & age-related diseases and cancer is projected to drive the market over the forecast period. Advancements in recombinant molecular technologies and high capitalization for development of novel drugs are also estimated to boost growth.
Favorable government initiatives for increasing focus toward generic drugs is a key factor for market growth. Decrease in generic drug prices, higher acceptance in low income and decrease in reimbursement for branded drugs are the recent trends in the market affirming growth of generic drugs.
Get Sample of this Report: http://www.grandviewresearch.com/industry-analysis/active-pharmaceutical-ingredients-market
Further Key Findings from the Study Suggest:
Grand View Research has segmented the API market by type of synthesis, type of manufacturer, type, applications, and region:
API Type of Synthesis Outlook (Revenue, USD Billion, 2014 – 2025)
API Type of Manufacturer Outlook (Revenue, USD Billion, 2014 – 2025)
API Type Outlook (Revenue, USD Billion, 2014 – 2025)
API Application Outlook (Revenue, USD Billion, 2014 – 2025)
API Regional Outlook (Revenue, USD Billion, 2014 – 2025)
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Corporate Sales Specialist, USA
Grand View Research, Inc
Toll Free: 1-888-202-9519
For More Information: www.grandviewresearch.com